Provided by Tiger Fintech (Singapore) Pte. Ltd.

Madrigal Pharmaceuticals

348.73
+3.761.09%
Post-market: 348.730.00000.00%18:11 EDT
Volume:362.02K
Turnover:126.18M
Market Cap:7.74B
PE:-19.41
High:352.00
Open:343.00
Low:343.00
Close:344.97
Loading ...

Madrigal Pharmaceuticals Q1 EPS USD -3.32

THOMSON REUTERS
·
01 May

Madrigal Pharmaceuticals Q1 Operating Expenses USD 216.561 Million

THOMSON REUTERS
·
01 May

Madrigal Pharmaceuticals Inc: First-Quarter 2025 Net Revenues of $137.3 Million

THOMSON REUTERS
·
01 May

Madrigal Pharmaceuticals announces six presentations at EASL Congress

TIPRANKS
·
29 Apr

Madrigal to Present Late-Breaking Resmetirom Data in Patients with Compensated MASH Cirrhosis at the EASL Congress

GlobeNewswire
·
29 Apr

Exploring High Growth Tech Stocks in the US Market

Simply Wall St.
·
29 Apr

Madrigal Pharmaceuticals Price Target Maintained With a $443.00/Share by JMP Securities

Dow Jones
·
24 Apr

Madrigal Pharmaceuticals to Release First-Quarter 2025 Financial Results and Host Webcast on May 1, 2025

GlobeNewswire
·
18 Apr

Madrigal Pharmaceuticals Announces Leadership Transition

TIPRANKS
·
18 Apr

BRIEF-Madrigal Pharmaceuticals Announces Company Founder Rebecca Taub, M.D. To Become Senior Scientific And Medical Advisor David Soergel, M.D., Appointed Chief Medical Officer

Reuters
·
16 Apr

Madrigal Pharmaceuticals Announces Company Founder Rebecca Taub, M.d. to Become Senior Scientific and Medical Advisor; David Soergel, M.d., Appointed Chief Medical Officer

THOMSON REUTERS
·
16 Apr

Is Madrigal Pharmaceuticals (MDGL) The Most Expensive Stock Insiders Are Dumping In March?

Insider Monkey
·
29 Mar

Exploring 3 High Growth Tech Stocks in the US Market

Simply Wall St.
·
29 Mar

Analysts Expect Breakeven For Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Before Long

Simply Wall St.
·
26 Mar

Madrigal Pharmaceuticals (MDGL): Among the Best Biotech Stocks to Buy According to Billionaires

Insider Monkey
·
18 Mar

Madrigal Pharmaceuticals appoints Fouse to its board of directors

TIPRANKS
·
11 Mar

Press Release: Madrigal Appoints Jacqualyn A. Fouse, Ph.D. to Its Board of Directors

Dow Jones
·
11 Mar

Madrigal Pharmaceuticals Exec Cashes Out in Multi-Million Dollar Stock Sale!

TIPRANKS
·
08 Mar

TD Cowen Sticks to Their Buy Rating for Madrigal Pharmaceuticals (MDGL)

TIPRANKS
·
06 Mar

B. Riley Upgrades Madrigal Pharmaceuticals to Buy From Neutral, Raises Price Target to $422 From $236

MT Newswires Live
·
28 Feb